AU2019253009B2 - A method of transporting mesenchymal stem cells by means of a transporting solution and a method of administering stem cells to wounds - Google Patents

A method of transporting mesenchymal stem cells by means of a transporting solution and a method of administering stem cells to wounds

Info

Publication number
AU2019253009B2
AU2019253009B2 AU2019253009A AU2019253009A AU2019253009B2 AU 2019253009 B2 AU2019253009 B2 AU 2019253009B2 AU 2019253009 A AU2019253009 A AU 2019253009A AU 2019253009 A AU2019253009 A AU 2019253009A AU 2019253009 B2 AU2019253009 B2 AU 2019253009B2
Authority
AU
Australia
Prior art keywords
cells
medium
glucose
glutamine
mesenchymal stem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2019253009A
Other languages
English (en)
Other versions
AU2019253009A1 (en
Inventor
Brian M. Freed
Toan Thang Phan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CellResearch Corp Pte Ltd
Original Assignee
CellResearch Corp Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CellResearch Corp Pte Ltd filed Critical CellResearch Corp Pte Ltd
Publication of AU2019253009A1 publication Critical patent/AU2019253009A1/en
Assigned to CELLRESEARCH CORPORATION PTE. LTD. reassignment CELLRESEARCH CORPORATION PTE. LTD. Request for Assignment Assignors: CELLRESEARCH CORPORATION PTE. LTD., THE REGENTS OF THE UNIVERSITY OF COLORADO
Application granted granted Critical
Publication of AU2019253009B2 publication Critical patent/AU2019253009B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/34—Sugars
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/40—Nucleotides, nucleosides or bases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Dispersion Chemistry (AREA)
  • Botany (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2019253009A 2018-04-09 2019-04-09 A method of transporting mesenchymal stem cells by means of a transporting solution and a method of administering stem cells to wounds Active AU2019253009B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862655198P 2018-04-09 2018-04-09
US62/655,198 2018-04-09
PCT/SG2019/050197 WO2019199229A1 (en) 2018-04-09 2019-04-09 A method of transporting mesenchymal stem cells by means of a transporting solution and a method of administering stem cells to wounds

Publications (2)

Publication Number Publication Date
AU2019253009A1 AU2019253009A1 (en) 2020-10-15
AU2019253009B2 true AU2019253009B2 (en) 2025-09-25

Family

ID=68098812

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2019253009A Active AU2019253009B2 (en) 2018-04-09 2019-04-09 A method of transporting mesenchymal stem cells by means of a transporting solution and a method of administering stem cells to wounds

Country Status (5)

Country Link
US (2) US11400119B2 (cg-RX-API-DMAC7.html)
EP (1) EP3772936A4 (cg-RX-API-DMAC7.html)
JP (2) JP7446619B2 (cg-RX-API-DMAC7.html)
AU (1) AU2019253009B2 (cg-RX-API-DMAC7.html)
WO (1) WO2019199229A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4040957A4 (en) * 2019-10-08 2023-11-01 CellResearch Corporation Pte. Ltd. MESENCHYMAL STEM CELL STORAGE OR TRANSPORT FORMULATION AND METHOD FOR THE PRODUCTION AND USE THEREOF
CN114585255A (zh) * 2019-11-08 2022-06-03 博傲沃德株式会社 干细胞用冷藏保存液
DE102021105020A1 (de) * 2021-03-02 2022-09-08 Carl Zeiss Microscopy Gmbh Mikroskopiesystem und Verfahren zum Verarbeiten eines Mikroskopbildes
JPWO2022239556A1 (cg-RX-API-DMAC7.html) * 2021-05-11 2022-11-17

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017096607A1 (zh) * 2015-12-11 2017-06-15 郭镭 一种从脐带外层羊膜组织中分离提取hUC-MSC的方法
WO2018067071A1 (en) * 2016-10-05 2018-04-12 Cellresearch Corporation Pte. Ltd. A method of isolating mesenchymal stem cells from umbilical cord amniotic membrane using a cell culture medium

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ553695A (en) 2004-08-16 2009-10-30 Cellres Corp Pte Ltd Isolation of stem/progenitor cells from amniotic membrane of umbilical cord
CN101330935B (zh) 2005-10-21 2013-11-13 细胞研究私人有限公司 自脐带羊膜分离和培养干/祖细胞及其分化的细胞的应用
CN103356710A (zh) 2007-02-12 2013-10-23 人类起源公司 利用胎盘干细胞治疗炎性疾病
EP2268796A1 (en) 2008-03-17 2011-01-05 Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Vectors and methods for generating vector-free induced pluripotent stem (ips) cells using site-specific recombination
EP2128245A1 (en) 2008-05-27 2009-12-02 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Generation of induced pluripotent stem (iPS) cells
WO2009155334A1 (en) * 2008-06-20 2009-12-23 Escape Therapeutics, Inc. Differentiation of mesenchymal stem cells into fibroblasts, compositions comprising mesenchymal stem cell-derived fibroblasts, and methods of using the same
GB0822246D0 (en) 2008-12-05 2009-01-14 Reneuron Ltd Composition
EP2218778A1 (en) 2009-02-16 2010-08-18 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Conversion of unipotent germline stem cells into pluripotent stem cells without exogenous factors
EP3142485B1 (en) 2014-05-12 2021-04-28 Roosterbio, Inc. Ready-to-print cells and integrated devices

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017096607A1 (zh) * 2015-12-11 2017-06-15 郭镭 一种从脐带外层羊膜组织中分离提取hUC-MSC的方法
WO2018067071A1 (en) * 2016-10-05 2018-04-12 Cellresearch Corporation Pte. Ltd. A method of isolating mesenchymal stem cells from umbilical cord amniotic membrane using a cell culture medium

Also Published As

Publication number Publication date
AU2019253009A1 (en) 2020-10-15
US11998569B2 (en) 2024-06-04
JP2024059760A (ja) 2024-05-01
JP7446619B2 (ja) 2024-03-11
EP3772936A1 (en) 2021-02-17
WO2019199229A1 (en) 2019-10-17
JP7804359B2 (ja) 2026-01-22
JP2021523883A (ja) 2021-09-09
US11400119B2 (en) 2022-08-02
EP3772936A4 (en) 2022-01-05
US20190307805A1 (en) 2019-10-10
US20230047491A1 (en) 2023-02-16

Similar Documents

Publication Publication Date Title
US12344861B2 (en) Method of isolating mesenchymal stem cells from the amniotic membrane of the umbilical cord, a mesenchymal stem cell population isolated from the amniotic membrane of the umbilical cord and a cell culture medium for isolating mesenchymal stem cells from the amniotic membrane of the umbilical cord
US11998569B2 (en) Method of transporting mesenchymal stem cells by means of a transporting solution and a method of administering stem cells to wounds
AU2019250653B2 (en) A method of inducing or improving wound healing properties of mesenchymal stem cells
US20210102171A1 (en) Mesenchymal stem cell storing or transport formulation and methods of making and using the same
WO2019199230A1 (en) A method of transporting mesenchymal stem cells by means of a cell culture medium and a method of administering stem cells to wounds
Zhu et al. Pluripotent stem cell derived cardiac cells for myocardial repair
US12460178B2 (en) Method of inducing or improving wound healing properties of mesenchymal stem cells
RU2836320C1 (ru) Композиция для хранения или транспортировки мезенхимальных стволовых клеток и способы ее приготовления и применения
HK40004787A (en) A method of isolating mesenchymal stem cells from umbilical cord amniotic membrane using a cell culture medium
HK40004787B (en) A method of isolating mesenchymal stem cells from umbilical cord amniotic membrane using a cell culture medium

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: CELLRESEARCH CORPORATION PTE. LTD.

Free format text: FORMER APPLICANT(S): CELLRESEARCH CORPORATION PTE. LTD.; THE REGENTS OF THE UNIVERSITY OF COLORADO

FGA Letters patent sealed or granted (standard patent)